Revascularization in patients with type 2 diabetes and coronary artery disease;Revaskularisation bei Patienten mit Typ-2-Diabetes und koronarer Herzkrankheit

Internist

Volumn 51, Issue 5, 2010, Pages 674-676

  Stork S ^a   Ertl, G ^a   Nitschmann, S ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OUTCOME ASSESSMENT; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KAPLAN-MEIER ESTIMATE; MALE; METFORMIN; MIDDLE AGED; MYOCARDIAL INFARCTION; STROKE; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 77955096589     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-010-2593-6     Document Type: Note

References (3)

1. Boden WE, O'Rourke RA, Teo KK et al. (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356: 1503-1516.
2. Bypass Angioplasty Revascularization Investigation (BARI) Investigators (1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335: 217-225.
3. Farkouh ME, Dangas G, Leon MB et al. (2008) Design of the future revascularization evaluation in patients with diabetes mellitus: optimal management of multivessel disease (FREEDOM) trial. Am Heart J 155: 215-223.